Internet-based Parent Training for Parents of Children With Externalising Behavior Problems (BIP-SAMBA)

April 22, 2021 updated by: Jens Högström, Karolinska Institutet

Internet-based Parent Training for Parents of Children With Externalising Behavior Problems: A Randomised Controlled Trial

The study aims to evaluate the efficacy of a 5-week, therapist-guided, internet-delivered parent management training program (BIP SAMBA) targeting children aged 5 - 11 years with externalising behavior problems. The study is a randomised controlled trial with parents of N=30 children participating. The intervention BIP SAMBA is compared with a waitlist control condition. Participants in the control condition will be crossed over to the active treatment after 5 weeks. The primary outcome measure is the Eyberg Child Behavior Inventory (ECBI) at the post treatment (5 weeks after baseline assessment).

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden, 113 30
        • BUP CPF

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 11 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Being parent of a child between 5 and 11 years
  • This child has externalising behavior problems
  • The parent has access to the internet
  • The parent speaks and write Swedish

Exclusion Criteria:

  • The child has an autism diagnosis
  • The child has severe conduct problems
  • There is domestic violence occurring within the family
  • There alcohol or substance abuse occurring within the family

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Internet-based parent training
Five weeks of therapist-guided online delivered parents training
Behavioral parent management training
No Intervention: Waitlist
Five weeks of waitlist

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Eyeberg Child Behavior Inventory (ECBI)
Time Frame: Change in conduct problems from baseline (week 0) to post-treatment (week 6)
Measures externalising behavior problems in children; Min: 0 Max 216; A higher score indicates worse conduct problems.
Change in conduct problems from baseline (week 0) to post-treatment (week 6)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Strength and Difficulties Questionnaire (SDQ)
Time Frame: Change in mental health issues from baseline (week 0) to post-treatment (week 6)
Measures conduct problems, emotional problems, ADHD symptoms, peer problems and prosocial behaviours; Min: 0 Max: 40p; A higher score indicate worse mental health problems Screens for behavioral problems, emotional problems, ADHD symptoms, peer problems and pro social behaviours
Change in mental health issues from baseline (week 0) to post-treatment (week 6)
Alabama Parenting Questionnaire (APQ)
Time Frame: Change in parenting strategies from baseline (week 0) to post-treatment (week 6)
Measures parenting strategies; Min: 0 Max: 76; A higher score indicates worse parenting strategies
Change in parenting strategies from baseline (week 0) to post-treatment (week 6)
Client Satisfaction Questionnaire (CSQ)
Time Frame: At post-treatment (week 6)
Measures satisfaction with a treatment that has been received; Min: 0 Max: 24; A higher score indicates better satisfaction with the treatment
At post-treatment (week 6)
Weekly questions about frequency of and impairment from behavior problems
Time Frame: Changes in behavior problems from baseline to week 5
Participants rate these two questions every week throughout the treatment; Min 0 Max: 9; A higher score indicates worse behavior problems
Changes in behavior problems from baseline to week 5

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 15, 2020

Primary Completion (Actual)

April 15, 2021

Study Completion (Actual)

April 15, 2021

Study Registration Dates

First Submitted

December 9, 2020

First Submitted That Met QC Criteria

December 15, 2020

First Posted (Actual)

December 17, 2020

Study Record Updates

Last Update Posted (Actual)

April 23, 2021

Last Update Submitted That Met QC Criteria

April 22, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2020-05262

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parenting

Clinical Trials on BIP SAMBA

3
Subscribe